There is current agreement on Th1 cells being committed to anti-tumor activities due to their roles in production of IFN-γ, macrophage activation, and priming and activation of cytotoxic CD8+ T cells, and the generation and maintenance of long-lived CD8+ T cells [20,84,85]. The gene discussed is IFNG; the disease is neoplasm.